Antitumorigenic effect of interferon-β by inhibition of undifferentiated glioblastoma cells

Shun Yamamuro, Emiko Sano, Yutaka Okamoto, Yushi Ochiai, Takashi Ohta, Akiyoshi Ogino, Atsushi Natsume, Toshihiko Wakabayashi, Takuya Ueda, Hiroyuki Hara, Tomohiro Nakayama, Atsuo Yoshino, Yoichi Katayama

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Glioma stem-like cells (GSCs) are undifferentiated cells that are considered to be an origin of glioblastomas. Furthermore, they may contribute to treatment resistance and recurrence in glioblastomas. GSCs differentiate into differentiated glioma cells (non-glioma stem-like cells: non.GSCs), and interconversion might occur between GSCs and non-GSCs. We investigated whether interferon-beta (IFN-β) could exert any efficacy towards GSCs or such interconversion processes. The neural stem cell marker CD133 and pluripotency marker Nanog in GSCs were analyzed to evaluate their differentiation levels. GSCs were considered to undergo differentiation into non-GSCs upon serum exposure, since the expression of CD133 and Nanog in the GSCs was negatively affected. Furthermore, the cells regained their undifferentiated features upon removal of the serum. However, we verified that IFN-β reduced cell proliferation and tumor sphere formation in GSCs, and induced suppression of the restoration of such undifferentiated features. In addition, we also confirmed that IFN-β suppressed the acquisition process of undifferentiated features in human malignant glioma cell lines. Our data thus suggest that IFN-β could be an effective agent not only through its cell growth inhibitory effect on GSCs but also as a means of targeting the interconversion between GSCs and non-GSCs, indicating the possibility of IFN-β being used to prevent treatment resistance and recurrence in glioblastomas, via the inhibition of undifferentiated features.

Original languageEnglish
Pages (from-to)1647-1654
Number of pages8
JournalInternational journal of oncology
Volume47
Issue number5
DOIs
Publication statusPublished - 2015 Nov 1
Externally publishedYes

Fingerprint

Glioblastoma
Interferons
Glioma
Stem Cells
Interferon-beta
Recurrence
Neural Stem Cells
Serum

Keywords

  • Differentiation
  • Glioblastoma
  • Glioma stem-like cells
  • Interferon
  • Undifferentiation

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Yamamuro, S., Sano, E., Okamoto, Y., Ochiai, Y., Ohta, T., Ogino, A., ... Katayama, Y. (2015). Antitumorigenic effect of interferon-β by inhibition of undifferentiated glioblastoma cells. International journal of oncology, 47(5), 1647-1654. https://doi.org/10.3892/ijo.2015.3165

Antitumorigenic effect of interferon-β by inhibition of undifferentiated glioblastoma cells. / Yamamuro, Shun; Sano, Emiko; Okamoto, Yutaka; Ochiai, Yushi; Ohta, Takashi; Ogino, Akiyoshi; Natsume, Atsushi; Wakabayashi, Toshihiko; Ueda, Takuya; Hara, Hiroyuki; Nakayama, Tomohiro; Yoshino, Atsuo; Katayama, Yoichi.

In: International journal of oncology, Vol. 47, No. 5, 01.11.2015, p. 1647-1654.

Research output: Contribution to journalArticle

Yamamuro, S, Sano, E, Okamoto, Y, Ochiai, Y, Ohta, T, Ogino, A, Natsume, A, Wakabayashi, T, Ueda, T, Hara, H, Nakayama, T, Yoshino, A & Katayama, Y 2015, 'Antitumorigenic effect of interferon-β by inhibition of undifferentiated glioblastoma cells', International journal of oncology, vol. 47, no. 5, pp. 1647-1654. https://doi.org/10.3892/ijo.2015.3165
Yamamuro, Shun ; Sano, Emiko ; Okamoto, Yutaka ; Ochiai, Yushi ; Ohta, Takashi ; Ogino, Akiyoshi ; Natsume, Atsushi ; Wakabayashi, Toshihiko ; Ueda, Takuya ; Hara, Hiroyuki ; Nakayama, Tomohiro ; Yoshino, Atsuo ; Katayama, Yoichi. / Antitumorigenic effect of interferon-β by inhibition of undifferentiated glioblastoma cells. In: International journal of oncology. 2015 ; Vol. 47, No. 5. pp. 1647-1654.
@article{36919f344a9a4b5d94165c58fc006e03,
title = "Antitumorigenic effect of interferon-β by inhibition of undifferentiated glioblastoma cells",
abstract = "Glioma stem-like cells (GSCs) are undifferentiated cells that are considered to be an origin of glioblastomas. Furthermore, they may contribute to treatment resistance and recurrence in glioblastomas. GSCs differentiate into differentiated glioma cells (non-glioma stem-like cells: non.GSCs), and interconversion might occur between GSCs and non-GSCs. We investigated whether interferon-beta (IFN-β) could exert any efficacy towards GSCs or such interconversion processes. The neural stem cell marker CD133 and pluripotency marker Nanog in GSCs were analyzed to evaluate their differentiation levels. GSCs were considered to undergo differentiation into non-GSCs upon serum exposure, since the expression of CD133 and Nanog in the GSCs was negatively affected. Furthermore, the cells regained their undifferentiated features upon removal of the serum. However, we verified that IFN-β reduced cell proliferation and tumor sphere formation in GSCs, and induced suppression of the restoration of such undifferentiated features. In addition, we also confirmed that IFN-β suppressed the acquisition process of undifferentiated features in human malignant glioma cell lines. Our data thus suggest that IFN-β could be an effective agent not only through its cell growth inhibitory effect on GSCs but also as a means of targeting the interconversion between GSCs and non-GSCs, indicating the possibility of IFN-β being used to prevent treatment resistance and recurrence in glioblastomas, via the inhibition of undifferentiated features.",
keywords = "Differentiation, Glioblastoma, Glioma stem-like cells, Interferon, Undifferentiation",
author = "Shun Yamamuro and Emiko Sano and Yutaka Okamoto and Yushi Ochiai and Takashi Ohta and Akiyoshi Ogino and Atsushi Natsume and Toshihiko Wakabayashi and Takuya Ueda and Hiroyuki Hara and Tomohiro Nakayama and Atsuo Yoshino and Yoichi Katayama",
year = "2015",
month = "11",
day = "1",
doi = "10.3892/ijo.2015.3165",
language = "English",
volume = "47",
pages = "1647--1654",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "5",

}

TY - JOUR

T1 - Antitumorigenic effect of interferon-β by inhibition of undifferentiated glioblastoma cells

AU - Yamamuro, Shun

AU - Sano, Emiko

AU - Okamoto, Yutaka

AU - Ochiai, Yushi

AU - Ohta, Takashi

AU - Ogino, Akiyoshi

AU - Natsume, Atsushi

AU - Wakabayashi, Toshihiko

AU - Ueda, Takuya

AU - Hara, Hiroyuki

AU - Nakayama, Tomohiro

AU - Yoshino, Atsuo

AU - Katayama, Yoichi

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Glioma stem-like cells (GSCs) are undifferentiated cells that are considered to be an origin of glioblastomas. Furthermore, they may contribute to treatment resistance and recurrence in glioblastomas. GSCs differentiate into differentiated glioma cells (non-glioma stem-like cells: non.GSCs), and interconversion might occur between GSCs and non-GSCs. We investigated whether interferon-beta (IFN-β) could exert any efficacy towards GSCs or such interconversion processes. The neural stem cell marker CD133 and pluripotency marker Nanog in GSCs were analyzed to evaluate their differentiation levels. GSCs were considered to undergo differentiation into non-GSCs upon serum exposure, since the expression of CD133 and Nanog in the GSCs was negatively affected. Furthermore, the cells regained their undifferentiated features upon removal of the serum. However, we verified that IFN-β reduced cell proliferation and tumor sphere formation in GSCs, and induced suppression of the restoration of such undifferentiated features. In addition, we also confirmed that IFN-β suppressed the acquisition process of undifferentiated features in human malignant glioma cell lines. Our data thus suggest that IFN-β could be an effective agent not only through its cell growth inhibitory effect on GSCs but also as a means of targeting the interconversion between GSCs and non-GSCs, indicating the possibility of IFN-β being used to prevent treatment resistance and recurrence in glioblastomas, via the inhibition of undifferentiated features.

AB - Glioma stem-like cells (GSCs) are undifferentiated cells that are considered to be an origin of glioblastomas. Furthermore, they may contribute to treatment resistance and recurrence in glioblastomas. GSCs differentiate into differentiated glioma cells (non-glioma stem-like cells: non.GSCs), and interconversion might occur between GSCs and non-GSCs. We investigated whether interferon-beta (IFN-β) could exert any efficacy towards GSCs or such interconversion processes. The neural stem cell marker CD133 and pluripotency marker Nanog in GSCs were analyzed to evaluate their differentiation levels. GSCs were considered to undergo differentiation into non-GSCs upon serum exposure, since the expression of CD133 and Nanog in the GSCs was negatively affected. Furthermore, the cells regained their undifferentiated features upon removal of the serum. However, we verified that IFN-β reduced cell proliferation and tumor sphere formation in GSCs, and induced suppression of the restoration of such undifferentiated features. In addition, we also confirmed that IFN-β suppressed the acquisition process of undifferentiated features in human malignant glioma cell lines. Our data thus suggest that IFN-β could be an effective agent not only through its cell growth inhibitory effect on GSCs but also as a means of targeting the interconversion between GSCs and non-GSCs, indicating the possibility of IFN-β being used to prevent treatment resistance and recurrence in glioblastomas, via the inhibition of undifferentiated features.

KW - Differentiation

KW - Glioblastoma

KW - Glioma stem-like cells

KW - Interferon

KW - Undifferentiation

UR - http://www.scopus.com/inward/record.url?scp=84942884540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942884540&partnerID=8YFLogxK

U2 - 10.3892/ijo.2015.3165

DO - 10.3892/ijo.2015.3165

M3 - Article

C2 - 26397698

AN - SCOPUS:84942884540

VL - 47

SP - 1647

EP - 1654

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 5

ER -